Relevance of High Bleeding Risk and Postdischarge Bleeding in Patients Undergoing Percutaneous Coronary Intervention

Area of Science:

• Cardiology
• Interventional Cardiology
• Pharmacotherapy

Background:

• Bleeding avoidance is critical in percutaneous coronary intervention (PCI).
• PCI complexity and high-risk patient populations have offset gains in reducing bleeding complications.
• Aggressive antiplatelet regimens in acute coronary syndrome prioritize ischemic event reduction over bleeding risk.

Purpose of the Study:

• To review contemporary and historical literature on bleeding avoidance strategies in PCI.
• To provide strategies for navigating complex decisions in antithrombotic therapy.
• To guide individualization of antithrombotic therapy based on patient-specific risks.

Main Methods:

• Comprehensive literature review using PubMed, EMBASE, and Cochrane Library.
• Analysis of procedural techniques and postdischarge pharmacotherapy.
• Evaluation of bleeding and ischemic risk factors.

Main Results:

• Improvements in procedural techniques and pharmacotherapy have been offset by increased PCI complexity in high-risk patients.
• Postdischarge bleeding carries a prognosis similar to ischemic events.
• Individualized risk assessment is essential for optimizing antithrombotic therapy.

Conclusions:

• Tailoring antithrombotic therapy by recognizing individual bleeding and ischemic risks is paramount for post-PCI outcomes.
• A personalized approach to pharmacotherapy can best balance the reduction of ischemic and bleeding events.
• This review offers guidance for clinicians managing antithrombotic therapy in PCI patients.